Research Updated.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 834, doi. 10.1016/j.ymthe.2005.03.041
- Publication type:
- Article
Works matching IS 15250016 AND DT 2006 AND VI 13 AND IP 5
Results: 23
1
2
Adventitious Mutations in Clinical Grade Vectors: An Issue to Consider?
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 831, doi. 10.1016/j.ymthe.2005.03.040
- By:
- Publication type:
- Article
3
Inside this Month.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 833, doi. 10.1016/j.ymthe.2006.03.016
- Publication type:
- Article
4
Mechanical and Metabolic Rescue in a Type II Diabetes Model of Cardiomyopathy by Targeted Gene Transfer.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 987, doi. 10.1016/j.ymthe.2006.01.002
- By:
- Publication type:
- Article
5
In Vivo Effects of Myeloablative Alkylator Therapy on Survival and Differentiation of MGMT<sup>P140K</sup>-Transduced Human G-CSF-Mobilized Peripheral Blood Cells.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 1016, doi. 10.1016/j.ymthe.2005.11.017
- By:
- Publication type:
- Article
6
Selective Intratumoral Amplification of an Antiangiogenic Vector by an Oncolytic Virus Produces Enhanced Antivascular and Anti-tumor Efficacy.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 938, doi. 10.1016/j.ymthe.2005.12.010
- By:
- Publication type:
- Article
7
Transduction of Myogenic Cells by Retargeted Dual High-Capacity Hybrid Viral Vectors: Robust Dystrophin Synthesis in Duchenne Muscular Dystrophy Muscle Cells.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 976, doi. 10.1016/j.ymthe.2005.11.018
- By:
- Publication type:
- Article
8
Gene Therapy for Diabetic Cardiomyopathy: A New Approach for a Difficult Problem.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 835, doi. 10.1016/j.ymthe.2006.03.013
- Publication type:
- Article
9
Gene Therapy for Lysosomal Storage Diseases.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 839, doi. 10.1016/j.ymthe.2006.01.006
- By:
- Publication type:
- Article
10
Dendritic Cell-Based Tumor Vaccines and Antigen Presentation Attenuators.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 850, doi. 10.1016/j.ymthe.2006.02.009
- By:
- Publication type:
- Article
11
Widespread Correction of Lysosomal Storage in the Mucopolysaccharidosis Type VII Mouse Brain with a Herpes Simplex Virus Type 1 Vector Expressing β-Glucuronidase.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 859, doi. 10.1016/j.ymthe.2005.12.017
- By:
- Publication type:
- Article
12
Intranasal Administration of the Growth-Compromised HSV-2 Vector ΔRR Prevents Kainate-Induced Seizures and Neuronal Loss in Rats and Mice.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 870, doi. 10.1016/j.ymthe.2005.12.013
- By:
- Publication type:
- Article
13
A Mutant Type 2 Herpes Simplex Virus Deleted for the Protein Kinase Domain of the ICP10 Gene Is a Potent Oncolytic Virus.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 882, doi. 10.1016/j.ymthe.2006.02.007
- By:
- Publication type:
- Article
14
Oncolytic Viruses Derived from the γ34.5-Deleted Herpes Simplex Virus Recombinant R3616 Encode a Truncated UL3 Protein.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 891, doi. 10.1016/j.ymthe.2006.02.006
- By:
- Publication type:
- Article
15
Targeted Therapy of DNA Tumor Virus-Associated Cancers Using Virus-Activated Transcription Factors.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 899, doi. 10.1016/j.ymthe.2005.11.023
- By:
- Publication type:
- Article
16
Blockade of TNF-α Decreases Both Inflammation and Efficacy of Intrapulmonary Ad.IFNβ Immunotherapy in an Orthotopic Model of Bronchogenic Lung Cancer.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 910, doi. 10.1016/j.ymthe.2005.12.012
- By:
- Publication type:
- Article
17
Immune Gene–Viral Therapy with Triplex Efficacy Mediated by Oncolytic Adenovirus Carrying an Interferon-γ Gene Yields Efficient Antitumor Activity in Immunodeficient and Immunocompetent Mice.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 918, doi. 10.1016/j.ymthe.2005.12.011
- By:
- Publication type:
- Article
18
Selective Targeting of Checkpoint Kinase 1 in Tumor Cells with a Novel Potent Oncolytic Adenovirus.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 928, doi. 10.1016/j.ymthe.2005.12.009
- By:
- Publication type:
- Article
19
Role of SCC-S2 in Experimental Metastasis and Modulation of VEGFR-2, MMP-1, and MMP-9 Expression.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 947, doi. 10.1016/j.ymthe.2005.11.020
- By:
- Publication type:
- Article
20
AAV Serotype 8-Mediated Gene Delivery of a Soluble VEGF Receptor to the CNS for the Treatment of Glioblastoma.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 956, doi. 10.1016/j.ymthe.2006.02.004
- By:
- Publication type:
- Article
21
Long-term Doxycycline-regulated Transgene Expression in the Retina of Nonhuman Primates Following Subretinal Injection of Recombinant AAV Vectors.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 967, doi. 10.1016/j.ymthe.2005.12.001
- By:
- Publication type:
- Article
22
Genetic Targeting of Adenovirus Vectors Using a Reovirus σ1-Based Attachment Protein.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 997, doi. 10.1016/j.ymthe.2005.11.019
- By:
- Publication type:
- Article
23
Sustained FVIII Expression and Phenotypic Correction of Hemophilia A in Neonatal Mice Using an Endothelial-Targeted Sleeping Beauty Transposon.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 1006, doi. 10.1016/j.ymthe.2005.11.021
- By:
- Publication type:
- Article